Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer
Clinical trial NCT04521348 · COMPLETED
Trial details
- NCT number
- NCT04521348
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2024-12-31
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.